|

A Multi-domain Lifestyle Intervention Among Aged Community-residents in Zhejiang, China

RECRUITINGN/ASponsored by Zhejiang University
Actively Recruiting
PhaseN/A
SponsorZhejiang University
Started2023-05-28
Est. completion2025-04-28
Eligibility
Age60 Years – 80 Years
Healthy vol.Accepted

Summary

A study conducted in Finland discovered that a multidomain intervention, consisting of physical activity, nutritional guidance, cognitive training, social activities, and management of vascular risk factors, effectively decelerated cognitive decline in healthy older adults who were at an increased risk of cognitive decline. The HERITAGE study is a 2-year clustered randomized controlled trial (clustered-RCT) that explores the efficacy of a multidomain intervention among 1200 elderly residents with a higher risk of cognitive decline and dementia in Zhejiang Province, China

Eligibility

Age: 60 Years – 80 YearsHealthy volunteers accepted
Inclusion Criteria:

* At risk of cognitive decline: cognitive performance at the mean level or slightly lower than expected for age with no dementia (AD8\>=3 and/or 5-min MoCA \>, \< 11)
* Free of physical disabilities that preclude participation in the study
* Willing to complete all study-related activities for 24 months
* Willing to be randomized to either lifestyle intervention group

Exclusion Criteria:

* Diagnosed dementia patients
* Diagnosed major depression or other neuropsychological diseases
* Malignant diseases
* Symptomatic cardiovascular disease
* Revascularization within one year
* Severe loss of vision, hearing or communicative ability

Conditions11

Alzheimer DiseaseAlzheimer's DiseaseBrain DiseasesCentral Nervous System DiseasesCognition DisorderCognitive ImpairmentDementMental DisorderNervous System DiseasesNeurocognitive Disorders

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.